[1] Iizuka N, Kuge S, Nomoto A. Complete nucleotide sequence of the genome of Coxsackievirus B1. Virology, 1987; 156, 64−73. doi:  10.1016/0042-6822(87)90436-3
[2] Huang SW, Cheng D, Wang JR. Enterovirus A71: virulence, antigenicity, and genetic evolution over the years. J Biomed Sci, 2019; 26, 81. doi:  10.1186/s12929-019-0574-1
[3] Oikarinen S, Tauriainen S, Hober D, et al. Virus antibody survey in different European populations indicates risk association between Coxsackievirus B1 and type 1 diabetes. Diabetes, 2014; 63, 655−62. doi:  10.2337/db13-0620
[4] Ji H, Fan H, Lu PX, et al. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu Province: epidemiology, etiology, and disease burden. BMC Infect Dis, 2019; 19, 79. doi:  10.1186/s12879-018-3659-7
[5] Guo W, Xu DH, Cong SR, et al. Co-infection and enterovirus B: post EV-A71 mass vaccination scenario in China. BMC Infect Dis, 2022; 22, 671. doi:  10.1186/s12879-022-07661-3
[6] Zhang M, Guo W, Xu DH, et al. Molecular characterization of echovirus 9 strains isolated from hand-foot-and-mouth disease in Kunming, Yunnan Province, China. Sci Rep, 2022; 12, 2293. doi:  10.1038/s41598-022-06309-1
[7] Chan YF, Sam IC, AbuBakar S. Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences. Infect Genet Evol, 2010; 10, 404−12. doi:  10.1016/j.meegid.2009.05.010
[8] Zhang J, Zhang HH, Zhao YL, et al. Molecular characterization of a new human coxsackievirus B2 associated with severe hand-foot-mouth disease in Yunnan Province of China in 2012. Arch Virol, 2017; 162, 307−11. doi:  10.1007/s00705-016-3075-5
[9] Lukashev AN, Lashkevich VA, Ivanova OE, et al. Recombination in circulating Human enterovirus B: independent evolution of structural and non-structural genome regions. J Gen Virol, 2005; 86, 3281−90. doi:  10.1099/vir.0.81264-0
[10] Xiao JB, Wang JX, Lu HH, et al. Genomic epidemiology and transmission dynamics of global Coxsackievirus B4. Viruses, 2023; 15, 569. doi:  10.3390/v15020569